In connection with hemophilia, Sun et al. published data showing that hemosiderin deposition in joints decreased in a mouse model of HemA when AAV8-FVIII was supplemented with recombinant AAV9-FactorVIIa, which was used to prevent the effects of autoinhibitory antibodies [63]. The gene discussed is F8; the disease is hemophilia A.